As CEO of THREAD, John leads their efforts to change the way clinical research is conducted focused on decentralized approaches, enabling the use of their one platform for conducting modern research studies and leading partnerships with their customers. After launching and growing THREAD, they were acquired in 2019 by JLL Partners and Water Street with strategic investment for continued growth and focus on accelerating drug development for our customers.
Read MoreThomas Celerier is heading their Healthcare, MedTech, and Life Sciences business, teams, and portfolio of clients for the Palo Alto Offices, Marcel Gradidge is a Director in the Business Advisory unit in the Silicon Valley Market and Gautam Narayan is a leader in the Emerge Supply Chain Division. All of them come from a diverse background managing global projects and teams and with experience in international relationships, with careers, professional and personal lives spanning multiple locations such as Australia, Colombia, Mexico, South Africa, Europe, India, and North America.
Read MoreMitchell is the President of H Clinical, the leader in decentralized trial and home health services for clinical trials across Latin America. With a 15-year passion for enabling clinical research, supporting life sciences, and transforming organizations, Mitchell is responsible for H Clinical’s strategy, business activities, and operations. Prior to H Clinical, Mitchell served as Managing Director, Everglade Rx, Executive VP & General Counsel, Advarra, and Associate Attorney, K&L Gates. Mitchell is on the Board of Directors for Life Science Washington, Faculty for RAPS, and a former Steering Committee Member for Harvard MRCT. He is a published author on FDA regulations and frequent speaker on technology in clinical research.
Read MoreChris Sedgwick is the Americas Trade Specialist at the Illinois Department of Commerce and Economic Opportunity Office of Trade and Investment. He has lived in Chicago for 9 years. Born in Los Angeles, he attended California State University Northridge where he received his Bachelor of Arts in French. As a student, he participated in the Junior Year Abroad program at the University of Aix-en-Provence in France. He later went on to receive his MBA from the Thunderbird Graduate School of Global Management in Glendale, AZ.
Read MoreDr. Uzbelger Feldman's mission is 'Smiles for All'. He is the first Hispanic dentist adopting Teledentistry and the first dentist implementing it in Ohio, Pennsylvania, Minnesota, and South Dakota since July 2018 as well as in Latin America. Due to his exceptional front-line services during the first month of the pandemic, Daniel received ‘The Teledentist of the Month’ award in March 2020. He received his IBM Blockchain Certificate in February 2018 and is currently innovating in blockchain for healthcare.
Read MoreKameel is the Principal of KDF Ventures LLC, venture capital and private equity firm. He is a leader in global finance with over 20 years of experience in established and emerging markets within the biopharmaceutical industry.
Prior to KDF Ventures, Kameel was the Senior Vice President of Finance at Ionis Pharmaceuticals, Inc the world leader in developing RNA-based human therapies. He also worked at Amgen, one of the world’s leading biotechnology companies, for 16 years. While at Amgen, Kameel held multiple leadership positions International operations and regional CFO roles of Latin America/Canada/Australia, Middle East, and Africa.
Read MoreJhonatan Bringas Dimitriades, MD is a Medical Doctor and executive who works with technologists, developers, medical professionals and patients to deliver the right digital and technical solutions to enhance the diagnosis, treatment, recovery and quality of life of patients around the globe.
Dr. Bringas believes in the democratization and digitalization of medicine. He Bringas has worked in the implementation of medical technologies in some of the top medical centers worldwide, such as the Mayo Clinic, the Cleveland Clinic, the Panama Clinic, the Hong Kong University Hospital, the AMC UMC Amsterdam and many others. His work is related to medical implementation of technologies, digital health, and innovation in the medical devices area.
Read MoreAlejandro Badia, MD, FACS is a hand and upper extremity surgeon at Badia Hand to Shoulder Center in Doral, Florida. Dr. Badia studied physiology at Cornell University and obtained his medical degree at NYU, where he also trained in orthopedics. A hand fellowship at Alleghany General Hospital in Pittsburgh was followed by an AO trauma fellowship in Freiburg, Germany. He runs an active international hand fellowship, serves on the editorial board of two hand journals, and previously organized a yearly Miami meeting for surgeons /therapists devoted to upper limb arthroscopy and arthroplasty. This international meeting was held at the world renowned Miami Anatomical Research Center ( M.A.R.C. ) , the worlds 2nd largest surgical cadaveric training lab which Dr. Badia co-founded in 2005. He is a founding member of the American Hand Institute, a think tank and medical device start-up company focused on minimally invasive solutions to hand, wrist and elbow pathology.
Read MoreAntonino was born and raised in Italy and moved to Mexico in 2016 as Latin America BD and Marketing Director for Ferring Pharmaceuticals. In 2018, he joined Mundipharma also as LATAM BD Director and then assumed the role of General Manager in Argentina. During his tenure in the pharma industry, Antonino has covered all commercial positions, including general management, business development & licensing, alliance management, project and transition leadership, marketing and sales, market access, pricing & reimbursement.
Read MoreDr. M. Samir Qamar is the CEO of MedWand, a telehealth technology company. Dr. Qamar invented the award-winning MedWand, a medical device that allows clinicians to examine patients over the Internet on smartphones and computers. The handheld MedWand advances the telemedicine industry by allowing clinicians to remotely obtain real-time vitals, auscultate heart and lungs, look into ears and throats, obtain EKGs, and monitor chronic conditions during video visits. Dr. Qamar has been on the company's board since co-founding the company and is also its chairman.
Read MoreRiley is helping new and existing telemedicine programs find the best solutions to fit their program needs. AMD has over 8500 patient end-point installations in more than 96 countries and delivers preeminent telemedicine solution design, turnkey installation, and training for telemedicine programs across the globe., including Latin America.
Read MoreJan Samzelius has specialized in quantitative methods for 40 years. Jan invented the typing cadence technology of NeuraMetrix. He has led a large number of analytical projects, ranging from measuring customer satisfaction to price elasticities to conjoint analyses. Mr. Samzelius has invented many new ways of conducting research into complex issues. His largest project was directing a reinvention of the customer satisfaction measurement system for a telecom. The high quality of the data made the unions accept instituting a bonus system for 9000 people. During the late 90s, Mr. Samzelius led an effort to enable a computer to understand the text. He has been the CEO of six companies, in several cases improving profits dramatically. His experience includes one turnaround and one successful exit.
Read More+15 years of experience in Cybersecurity, Cloud Computing; +4 years of experience in Blockchain & Bioinformatics. Recently specializes in Bioethics, Genomic & Healthcare Data. He Holds a Bs. Electronics Engineering, MBA from IPADE Business School, Executive Programs in Stanford GSB, Singularity University, Data Science at Galvanize, Digital Marketing at General Assembly & RNAseq at EcSeq Bioinformatics GmbH (Berlin).
Read MoreFrank is the Founder and President of Ation Advisory Group where he is helping Global Life Science Companies to commercialize their product, service, or technology along with obtaining dilutive and non-dilutive funding. As a retired Pfizer Executive Frank worked for over 25 years in positions of increased responsibility in Finance, Strategy, & Operations. Frank lead the Supply Chain & Finance functions across 35 countries in Asia, Eastern Europe, Latin America (where he supported 9 countries), and the Middle East. Frank currently sits on the Area Board of The American Cancer Society. Frank holds a BS in Accounting from Providence College and an MBA in International Finance at NYU Stern School of Business.
Gerardo is a C-Level executive, serial entrepreneur, inventor, and scholar in the medical device industry. Gerardo founded five medical device companies and is a consultant to over 50 medical device companies in the Silicon Valley area. Gerardo is an advisory board member of the Santa Clara University (SCU) BioE, the University of California in San Francisco (UCSF) Catalyst Program, the UCSF Surgical Consortium, and the Simon Fraser University Bioengineering Innovation Blvd. He is also an adjunct professor at the SCU graduate school of bioengineering.
As a serial entrepreneur, Gerardo identifies unmet clinical needs, assesses new business opportunities worldwide, and develops new technologies with strong Intellectual property rights. His hands-on experience resides in bringing new technologies from inception to full commercialization under a “vision and execution” type of approach.
Read MoreDr. Enrique Saldívar received his medical training in Universidad La Salle, received his MD from Universidad Autonoma de Mexico (UNAM), his Masters in Biomedical Engineering from Universidad Autonoma Metropolitana, and his Ph.D. in Bioengineering from the University of California, San Diego. Throughout his career, he has been appointed faculty at The Scripps Research Institute, La Jolla Bioengineering Institute, The West Wireless Health Institute, and Case Western Reserve University. His expertise includes: Biomechanics, Microcirculation, Rheology, Platelet Engineering, Digital Signal Processing, Image Processing, Bio-Micro-Electro-Mechanical Systems (Bio-MEMS), Nanotechnology, and Digital Health.
Hailing from a family of tech industrialists and medical thought leaders, Bjorn possesses a native drive and understanding for applying technologies to solve challenges in healthcare. Bjorn earned his M.Sc. in Accounting and Finance from the London School of Economics and B.Sc. from European Business School in Oestrich-Winkel, where he graduated in the top 3% and 10% of his class respectively.
Andrés Herrero is responsible for the European operations of i²medi, he is leading the i²medi's German office in Berlin and principal contact for the medical device manufacturers. Andrés has over 10 years of experience in sales and business development in Latin America and successfully introduced several new medical devices into the global healthcare markets- including Latin America.
Read MoreJames Sapirstein has served over thirty-five years in the pharmaceutical industry. He is currently the President and CEO of AzurRx BioPharma (AZRX:NASDAQ). He has been part of almost two dozen drug product launches and specifically either led or has been a key member of several HIV product launches into different new classes of therapeutics at the time.
Mr. Sapirstein holds board positions on Marizyme (MRZM) (Executive Chairman) Enochian Biosciences (ENOB), and Leading Biosciences. He was Chairman of the Board for BioNJ, an association of biopharma industries in New Jersey from Feb 2017 to Feb 2019. In addition, he is a Board Director for BIO, the leading Biopharma Industries Organization promoting public policy and networking in the healthcare space, where he sits on both the Health Section and Emerging Companies Section Governing Boards. Mr. Sapirstein received an MBA from Fairleigh Dickinson University in 1997, and a BS (Pharmacy) from Rutgers University in 1984.
Read MoreOscar Segurado is an executive veteran of the biopharmaceutical industry with extensive global leadership experience in translational science, clinical development, and medical affairs. Oscar is Chief Medical Officer for ASC Therapeutics, former CMO for Symvivo, Myriad Genetics, and CellMax Life, Vice President for Becton Dickinson, and Global Medical Head for Abbott/AbbVie.
Segurado is a senior medical leader experienced in matrixed, line management, and consulting for biotechs, midsize, and large pharma companies. Extensive expertise in gene therapy, immuno-oncology, immunotherapy, genomics, and protein/cell diagnostics, predominantly focused on oncology, hematology, and autoimmunity, including personalized medicine, molecular and cellular biomarkers. He holds a tenured Professorship of Immunology at the University of Leon, Spain, and received Ph.D. from the University of Wuerzburg, Germany, and MD from the University of Salamanca, Spain.
Read MoreJeff Galvin is the CEO and Founder of American Gene TechnologiesTM (AGT). He earned his BA degree in Economics from Harvard in 1981 and has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups. Several of his companies were taken public and/or sold to public companies, including one in the medical-technology arena that was sold to Varian, the leading maker of linear accelerators used in cancer therapy. Following his startup experience, he retired to become an Angel Investor in real estate and high tech. He came out of retirement to found and fund AGT after meeting Roscoe Brady at NIH.
Read More
